Copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Nov 6, 2020; 8(21): 5188-5202
Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5188
Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5188
Epidemiological and clinical characteristics of fifty-six cases of COVID-19 in Liaoning Province, China
Jing-Bo Wang, Lei-Shi Wang, Jiao Xv, Chun Xv, Xing-Hai Li, Hong-Yan Liu, Bai-Jun Li, Hong Yu, Xia Tian, Yan Wang, Rui Zhao, Wei Wang, Ye Gu, Department of Infectious Disease, The Sixth People’s Hospital of Shenyang, Shenyang 110006, Liaoning Province, China
Hai-Tao Wang, Department of General Surgery, The Second Affiliated Hospital of Shenyang Medical College, Shenyang 110002, Liaoning Province, China
Lu-Ping Li, Department of Clinical Laboratory, The Sixth People’s Hospital of Shenyang, Shenyang 110006, Liaoning Province, China
Yun-Hai Wu, Department of Intensive Critical Medicine, The Sixth People’s Hospital of Shenyang, Shenyang 110006, Liaoning Province, China
Zhi-Yu Zhang, Jin-Yang Liu, Department of Infectious Diseases Clinic, The Sixth People’s Hospital of Shenyang, Shenyang 110006, Liaoning Province, China
Author contributions: Wang JB, Wang HT, and Gu Y designed the research study; Wang HT and Gu Y provided administrative support; Li XH, Wu YH, Liu HY, Li BJ, Yu H, Tian X, Zhang ZY, Wang Y, Zhao R, Liu JY, and Wang W performed the research and provided clinical advice; Wang JB, Wang LS, Li LP, Xu J, Xu C, and Wang HT contributed to the analysis; Wang JB and Wang HT wrote the manuscript; All authors have read and approve the final manuscript.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of The Sixth People’s Hospital of Shenyang.
Informed consent statement: Written informed consent was not obtained due to the urgent need for clinical data.
Conflict-of-interest statement: We have no financial relationships to disclose.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ye Gu, MD, Chief Doctor, Department of Infectious Disease, The Sixth People’s Hospital of Shenyang, No. 85 Hepingnan Street, Shenyang 110006, Liaoning Province, China. gu3311@126.com
Received: May 12, 2020
Peer-review started: May 12, 2020
First decision: August 21, 2020
Revised: August 31, 2020
Accepted: September 22, 2020
Article in press: September 22, 2020
Published online: November 6, 2020
Processing time: 177 Days and 22 Hours
Peer-review started: May 12, 2020
First decision: August 21, 2020
Revised: August 31, 2020
Accepted: September 22, 2020
Article in press: September 22, 2020
Published online: November 6, 2020
Processing time: 177 Days and 22 Hours
Core Tip
Core Tip: This is a retrospective, single-center study on the clinical characteristics of laboratory-confirmed coronavirus disease 2019 (COVID-19) cases caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We summarized the clinical data of 56 patients with COVID-19 diagnosed and treated in Liaoning. The main conclusion is SARS-CoV-2 can be transmitted among humans, and cases were mainly imported and were moderate. Severe cases were characterized by severe hypoxemia, lymphocytopenia, pulmonary consolidation, admittance to intensive care unit, and mechanical ventilation. Infection of SARS-CoV-2 and seriousness of COVID-19 are related to old age and underlying diseases.